Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress-mediated cell death in multiple myeloma cells

The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)-proteasome...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of oncology Vol. 46; no. 2; pp. 474 - 486
Main Authors MORIYA, SHOTA, KOMATSU, SEIICHIRO, YAMASAKI, KAHO, KAWAI, YUSUKE, KOKUBA, HIROKO, HIROTA, AYAKO, CHE, XIAO-FANG, INAZU, MASATO, GOTOH, AKIHIKO, HIRAMOTO, MASAKI, MIYAZAWA, KEISUKE
Format Journal Article
LanguageEnglish
Published Greece D.A. Spandidos 01.02.2015
Spandidos Publications
Spandidos Publications UK Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)-proteasome and autophagy-lysosome pathways leads to enhanced multiple myeloma (MM) cell apoptosis induction via stress overloading of the endoplasmic reticulum (ER). As misfolded protein cargo is recruited by histone deacetylase 6 (HDAC6) to dynein motors for aggresome transport, serving to sequester misfolded proteins, we further investigated the cellular effects of targeting proteolytic pathways and aggresome formation concomitantly in MM cells. Pronounced apoptosis was induced by the combination of vorinostat [suberoylanilide hydroxamic acid (SAHA); potently inhibits HDAC6] with CAM and BZ compared with each reagent or a 2-reagent combination. CAM/BZ treatment induced vimentin positive-aggresome formation along with the accumulation of autolysosomes in the perinuclear region, whereas they were inhibited in the presence of SAHA. The SAHA/CAM/BZ combination treatment maximally upregulated genes related to ER stress including C/EBP homologous protein (CHOP). Similarly to MM cell lines, enhanced cytotoxicity with CHOP upregulation following SAHA/CAM/BZ treatment was shown by a wild-type murine embryonic fibroblast (MEF) cell line; however, a CHOP-deficient MEF cell line almost completely canceled this pronounced cytotoxicity. Knockdown of HDAC6 with siRNA exhibited further enhanced CAM/BZ-induced cytotoxicity and CHOP induction along with the cancellation of aggresome formation. Targeting the integrated networks of aggresome, proteasome, and autophagy is suggested to induce efficient ER stress-mediated apoptosis in MM cells.
AbstractList The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)‑proteasome and autophagy‑lysosome pathways leads to enhanced multiple myeloma (MM) cell apoptosis induction via stress overloading of the endoplasmic reticulum (ER). As misfolded protein cargo is recruited by histone deacetylase 6 (HDAC6) to dynein motors for aggresome transport, serving to sequester misfolded proteins, we further investigated the cellular effects of targeting proteolytic pathways and aggresome formation concomitantly in MM cells. Pronounced apoptosis was induced by the combination of vorinostat [suberoylanilide hydroxamic acid (SAHA); potently inhibits HDAC6] with CAM and BZ compared with each reagent or a 2‑reagent combination. CAM/BZ treatment induced vimentin positive‑aggresome formation along with the accumulation of autolysosomes in the perinuclear region, whereas they were inhibited in the presence of SAHA. The SAHA/CAM/BZ combination treatment maximally upregulated genes related to ER stress including C/EBP homologous protein (CHOP). Similarly to MM cell lines, enhanced cytotoxicity with CHOP upregulation following SAHA/CAM/BZ treatment was shown by a wild‑type murine embryonic fibroblast (MEF) cell line; however, a CHOP‑deficient MEF cell line almost completely canceled this pronounced cytotoxicity. Knockdown of HDAC6 with siRNA exhibited further enhanced CAM/BZ‑induced cytotoxicity and CHOP induction along with the cancellation of aggresome formation. Targeting the integrated networks of aggresome, proteasome, and autophagy is suggested to induce efficient ER stress‑mediated apoptosis in MM cells.
The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)-proteasome and autophagy-lysosome pathways leads to enhanced multiple myeloma (MM) cell apoptosis induction via stress overloading of the endoplasmic reticulum (ER). As misfolded protein cargo is recruited by histone deacetylase 6 (HDAC6) to dynein motors for aggresome transport, serving to sequester misfolded proteins, we further investigated the cellular effects of targeting proteolytic pathways and aggresome formation concomitantly in MM cells. Pronounced apoptosis was induced by the combination of vorinostat [suberoylanilide hydroxamic acid (SAHA); potently inhibits HDAC6] with CAM and BZ compared with each reagent or a 2-reagent combination. CAM/BZ treatment induced vimentin positive-aggresome formation along with the accumulation of autolysosomes in the perinuclear region, whereas they were inhibited in the presence of SAHA. The SAHA/CAM/BZ combination treatment maximally upregulated genes related to ER stress including C/EBP homologous protein (CHOP). Similarly to MM cell lines, enhanced cytotoxicity with CHOP upregulation following SAHA/CAM/BZ treatment was shown by a wild-type murine embryonic fibroblast (MEF) cell line; however, a CHOP-deficient MEF cell line almost completely canceled this pronounced cytotoxicity. Knockdown of HDAC6 with siRNA exhibited further enhanced CAM/BZ-induced cytotoxicity and CHOP induction along with the cancellation of aggresome formation. Targeting the integrated networks of aggresome, proteasome, and autophagy is suggested to induce efficient ER stress-mediated apoptosis in MM cells. Key words: multiple myeloma, aggresome, proteasome, autophagy, ER stress
Audience Academic
Author CHE, XIAO-FANG
YAMASAKI, KAHO
KOKUBA, HIROKO
HIROTA, AYAKO
MORIYA, SHOTA
KOMATSU, SEIICHIRO
KAWAI, YUSUKE
HIRAMOTO, MASAKI
MIYAZAWA, KEISUKE
INAZU, MASATO
GOTOH, AKIHIKO
AuthorAffiliation 4 Institute of Medical Science, Tokyo Medical University, Tokyo, Japan
1 Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
2 Department of Breast Oncology, Tokyo Medical University, Tokyo, Japan
3 Laboratory of Electron Microscopy, Tokyo Medical University, Tokyo, Japan
5 Department of Hematology, Juntendo University, Tokyo, Japan
AuthorAffiliation_xml – name: 2 Department of Breast Oncology, Tokyo Medical University, Tokyo, Japan
– name: 1 Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
– name: 4 Institute of Medical Science, Tokyo Medical University, Tokyo, Japan
– name: 5 Department of Hematology, Juntendo University, Tokyo, Japan
– name: 3 Laboratory of Electron Microscopy, Tokyo Medical University, Tokyo, Japan
Author_xml – sequence: 1
  givenname: SHOTA
  surname: MORIYA
  fullname: MORIYA, SHOTA
  organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
– sequence: 2
  givenname: SEIICHIRO
  surname: KOMATSU
  fullname: KOMATSU, SEIICHIRO
  organization: Department of Breast Oncology, Tokyo Medical University, Tokyo, Japan
– sequence: 3
  givenname: KAHO
  surname: YAMASAKI
  fullname: YAMASAKI, KAHO
  organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
– sequence: 4
  givenname: YUSUKE
  surname: KAWAI
  fullname: KAWAI, YUSUKE
  organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
– sequence: 5
  givenname: HIROKO
  surname: KOKUBA
  fullname: KOKUBA, HIROKO
  organization: Laboratory of Electron Microscopy, Tokyo Medical University, Tokyo, Japan
– sequence: 6
  givenname: AYAKO
  surname: HIROTA
  fullname: HIROTA, AYAKO
  organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
– sequence: 7
  givenname: XIAO-FANG
  surname: CHE
  fullname: CHE, XIAO-FANG
  organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
– sequence: 8
  givenname: MASATO
  surname: INAZU
  fullname: INAZU, MASATO
  organization: Institute of Medical Science, Tokyo Medical University, Tokyo, Japan
– sequence: 9
  givenname: AKIHIKO
  surname: GOTOH
  fullname: GOTOH, AKIHIKO
  organization: Department of Hematology, Juntendo University, Tokyo, Japan
– sequence: 10
  givenname: MASAKI
  surname: HIRAMOTO
  fullname: HIRAMOTO, MASAKI
  organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
– sequence: 11
  givenname: KEISUKE
  surname: MIYAZAWA
  fullname: MIYAZAWA, KEISUKE
  organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25422130$$D View this record in MEDLINE/PubMed
BookMark eNp1UluL1DAYLbLiXvTRVwkI-rIdc-vtZWFZ1gssCLI-hzT92mZsm5qkyvwS_67fzOyuO6IkkJDvnJOTfOc0OZrcBEnyktGVKCv-zq7dilMmV7woxJPkhBUVS7nk4gj3lFVpLkV1nJyGsKaUZxllz5JjnknOmaAnya9b7TuIdupI7IHYKULndYSGTBB_Ov8tENcS3XUeghuBtM6POlo3nZPZuwh6e3pO9NQQvUQ397rbkBkLU7QoE8j1FxIikkM6QmN3ygaGgTSgY4_3kXEZop0HIOMGBjfqXTk8T562egjw4m49S76-v769-pjefP7w6eryJjU5YzEtueEG8rLVnLfCcFoJCVVhipKZGjIKRY2zKkqZUdPUdVYXmja50RWAlGUuzpKLve681GjQoG-vBzV7O2q_UU5bdViZbK8690NJ_G8uMxR4fSfg3fcFQlRrt_gJPStWCV5yWVH5B9XpAZSdWodiZrTBqEtJmSgZukHU6h8oHA2M1mDfW4vnB4Q3jwg96CH2wQ3LtkHhEPjq8TMf3ncfBASIPcB4F4KHVhkbd41GC3ZQjKpt3BTGTW3jprZxQ1b6F-te-H_4t3t8mDExtnHhgYDAVOYp5SmVhRS_Ac2O5jY
CitedBy_id crossref_primary_10_1002_med_21972
crossref_primary_10_1038_s41420_022_01293_x
crossref_primary_10_1186_s13046_024_03071_2
crossref_primary_10_1186_s13256_017_1550_6
crossref_primary_10_3892_ol_2023_14146
crossref_primary_10_1074_jbc_M116_717793
crossref_primary_10_3892_ijo_2015_3237
crossref_primary_10_3389_fimmu_2021_795053
crossref_primary_10_3390_cancers16132381
crossref_primary_10_3892_ol_2021_12941
crossref_primary_10_1016_j_celrep_2020_107897
crossref_primary_10_1038_s41598_020_73298_4
crossref_primary_10_2174_1389450121666200525004714
crossref_primary_10_1111_febs_14811
crossref_primary_10_3892_ijo_2016_3673
crossref_primary_10_1038_s41598_019_49027_x
crossref_primary_10_18632_oncotarget_17862
crossref_primary_10_3390_cancers14205072
crossref_primary_10_3892_or_2017_5932
crossref_primary_10_1016_j_bbrc_2018_05_001
crossref_primary_10_1039_C5SC01351H
crossref_primary_10_1016_j_jbc_2024_107398
crossref_primary_10_1016_j_jgg_2024_07_017
crossref_primary_10_3390_ijms24076019
crossref_primary_10_1038_s41416_023_02210_4
crossref_primary_10_1016_j_devcel_2020_03_011
crossref_primary_10_1016_j_ebiom_2023_104961
crossref_primary_10_1186_s12989_021_00430_1
crossref_primary_10_1016_j_eurpolymj_2024_113267
crossref_primary_10_1016_j_ejphar_2016_08_026
crossref_primary_10_20517_cdr_2023_108
crossref_primary_10_1016_j_canlet_2024_216978
crossref_primary_10_1248_bpb_b18_00785
crossref_primary_10_1016_j_canlet_2019_02_003
crossref_primary_10_1158_1541_7786_MCR_15_0135
crossref_primary_10_1080_10428194_2017_1376741
crossref_primary_10_1111_cas_14992
crossref_primary_10_1016_j_bbrc_2018_09_177
crossref_primary_10_1016_j_leukres_2016_07_006
crossref_primary_10_1016_j_bbrc_2015_03_162
crossref_primary_10_1007_s11060_020_03694_3
Cites_doi 10.3892/ijo.2013.1870
10.1056/NEJMoa030288
10.1083/jcb.146.6.1239
10.1038/emboj.2009.405
10.1101/sqb.2011.76.011023
10.3892/ijo.2011.1317
10.1074/jbc.M111.273730
10.1038/emboj.2013.171
10.1007/s00401-013-1158-x
10.1586/14737175.6.9.1337
10.1053/j.seminoncol.2013.07.007
10.1038/nature06639
10.1038/ncb0311-184
10.1016/j.ymgme.2008.03.012
10.1038/nrd3976
10.1073/pnas.0430973100
10.3109/0284186X.2012.689113
10.1182/blood-2012-05-425934
10.1016/j.bbrc.2013.06.032
10.1056/NEJMoa0801479
10.1016/j.molcel.2009.04.026
10.1083/jcb.143.7.1883
10.1172/JCI46095
10.1155/2010/930509
10.1371/journal.pone.0040440
10.1038/ncomms3111
10.1182/blood-2013-07-517276
10.2146/ajhp090247
10.1038/417455a
10.1247/csf.23.33
10.1016/S1470-2045(13)70398-X
10.1016/S0092-8674(03)00939-5
10.1016/j.febslet.2009.12.047
10.1371/journal.pone.0076016
10.1200/JCO.2006.10.2434
10.1182/blood-2007-12-130823
10.1128/MCB.00103-14
ContentType Journal Article
Copyright Copyright © 2015, Spandidos Publications
COPYRIGHT 2015 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2015
Copyright © 2015, Spandidos Publications 2015
Copyright_xml – notice: Copyright © 2015, Spandidos Publications
– notice: COPYRIGHT 2015 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2015
– notice: Copyright © 2015, Spandidos Publications 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOI 10.3892/ijo.2014.2773
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList MEDLINE




ProQuest One Academic Middle East (New)

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1791-2423
EndPage 486
ExternalDocumentID PMC4277245
A401381448
25422130
10_3892_ijo_2014_2773
ijo-46-02-0474
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID -
0R
2WC
3V.
53G
5GY
7RV
7X7
88E
8FI
8FJ
AAPBV
AASXA
ABFLS
ABPMR
ABUWG
ACGFS
ADACO
ADBBV
ADCBC
AENEX
AFKRA
AGCAB
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AN0
BAWUL
BBAFP
BENPR
BKEYQ
BNQBC
BPHCQ
BVXVI
C45
CS3
DIK
DU5
E3Z
EBD
EBS
EJD
F5P
FYUFA
H13
HUR
HZ
IAO
IHR
IHW
INH
INR
ITC
L7B
M1P
O9-
OGEVE
OVD
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
RIG
SV3
UDS
ZXP
---
0R~
AAFWJ
AAYXX
ABJNI
ACGFO
AEGXH
AFOSN
AIAGR
ALIPV
CCPQU
CITATION
EMOBN
HMCUK
HZ~
IPNFZ
NAPCQ
ODZKP
OK1
PHGZM
PHGZT
TEORI
TR2
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
5PM
ID FETCH-LOGICAL-c611t-82c2ce68fa22f3c20934e97c781cbe50e7be7b978450cdbb5b7a0d6ca9ee44863
IEDL.DBID 7X7
ISSN 1019-6439
IngestDate Thu Aug 21 18:34:25 EDT 2025
Fri Jul 25 05:48:16 EDT 2025
Tue Jun 17 21:32:03 EDT 2025
Tue Jun 10 20:26:57 EDT 2025
Thu May 22 21:24:46 EDT 2025
Thu Jan 02 22:16:53 EST 2025
Tue Jul 01 03:20:41 EDT 2025
Thu Apr 24 22:58:05 EDT 2025
Tue Jan 05 23:28:36 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c611t-82c2ce68fa22f3c20934e97c781cbe50e7be7b978450cdbb5b7a0d6ca9ee44863
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC4277245
PMID 25422130
PQID 1932824904
PQPubID 2044957
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4277245
proquest_journals_1932824904
gale_infotracmisc_A401381448
gale_infotracacademiconefile_A401381448
gale_healthsolutions_A401381448
pubmed_primary_25422130
crossref_citationtrail_10_3892_ijo_2014_2773
crossref_primary_10_3892_ijo_2014_2773
spandidos_primary_ijo-46-02-0474
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-02-01
PublicationDateYYYYMMDD 2015-02-01
PublicationDate_xml – month: 02
  year: 2015
  text: 2015-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle International journal of oncology
PublicationTitleAlternate Int J Oncol
PublicationYear 2015
Publisher D.A. Spandidos
Spandidos Publications
Spandidos Publications UK Ltd
Publisher_xml – name: D.A. Spandidos
– name: Spandidos Publications
– name: Spandidos Publications UK Ltd
References Moriya, Che, Komatsu, Abe, Kawaguchi, Gotoh, Inazu, Tomoda, Miyazawa (b16-ijo-46-02-0474) 2013; 42
Haggarty, Koeller, Wong, Grozinger, Schreiber (b28-ijo-46-02-0474) 2003; 100
Yamamoto, Tagawa, Yoshimori, Moriyama, Masaki, Tashiro (b37-ijo-46-02-0474) 1998; 23
Richardson, Xie, Jagannath (b3-ijo-46-02-0474) 2014; 123
Komatsu, Moriya, Che, Yokoyama, Kohno, Miyazawa (b24-ijo-46-02-0474) 2013; 437
Lee, Koga, Kawaguchi (b21-ijo-46-02-0474) 2010; 29
Tabas, Ron (b9-ijo-46-02-0474) 2011; 13
Simms-Waldrip, Rodriguez-Gonzalez, Lin, Ikeda, Fu, Sakamoto (b18-ijo-46-02-0474) 2008; 94
Zaarur, Meriin, Bejarano, Xu, Gabai, Cuervo, Sherman (b35-ijo-46-02-0474) 2014; 34
Mizushima, Levine, Cuervo, Klionsky (b11-ijo-46-02-0474) 2008; 451
Garcia-Mata, Bebök, Sorscher, Sztul (b29-ijo-46-02-0474) 1999; 146
Johnston, Ward, Kopito (b30-ijo-46-02-0474) 1998; 143
Nakamura, Kikukawa, Takeya, Mitsuya, Hata (b36-ijo-46-02-0474) 2010; 37
Renna, Schaffner, Brown (b38-ijo-46-02-0474) 2011; 121
Yan, Seibenhener, Calderilla-Barbosa, Diaz-Meco, Moscat, Jiang, Wooten, Wooten (b23-ijo-46-02-0474) 2013; 8
Hetz, Chevet, Harding (b8-ijo-46-02-0474) 2013; 12
Kirkin, McEwan, Novak, Dikic (b13-ijo-46-02-0474) 2009; 34
San Miguel, Schlag, Khuageva (b2-ijo-46-02-0474) 2008; 359
Richardson, Barlogie, Berenson (b1-ijo-46-02-0474) 2003; 348
Mizushima (b12-ijo-46-02-0474) 2011; 76
Komatsu, Miyazawa, Moriya, Takase, Naito, Inazu, Kohno, Itoh, Tomoda (b17-ijo-46-02-0474) 2012; 40
Siegel, Martin, Wang (b4-ijo-46-02-0474) 2012; 120
Verfaillie, Salazar, Velasco, Agostinis (b10-ijo-46-02-0474) 2010; 2010
Kawaguchi, Miyazawa, Moriya, Ohtomo, Che, Naito, Itoh, Tomoda (b15-ijo-46-02-0474) 2011; 38
Kavanaugh, White, Kolesar (b26-ijo-46-02-0474) 2010; 67
Hubbert, Guardiola, Shao, Kawaguchi, Ito, Nixon, Yoshida, Wang, Yao (b27-ijo-46-02-0474) 2002; 417
Olsen, Kim, Kuzel (b25-ijo-46-02-0474) 2007; 25
Kawaguchi, Kovacs, McLaurin, Vance, Ito, Yao (b19-ijo-46-02-0474) 2003; 115
Orlowski (b6-ijo-46-02-0474) 2013; 40
Fusco, Micale, Egorov (b22-ijo-46-02-0474) 2012; 7
Maejima, Takahashi, Omori (b39-ijo-46-02-0474) 2013; 32
Martinon (b7-ijo-46-02-0474) 2012; 51
Hung, Chen, Yang, Yang (b31-ijo-46-02-0474) 2013; 4
Dimopoulos, Siegel, Lonial (b5-ijo-46-02-0474) 2013; 14
Ouyang, Ali, Ravichandran, Dong, Qiu, MacKenzie, Dhe-Paganon, Arrowsmith, Zhai (b20-ijo-46-02-0474) 2012; 287
Richter-Landsberg, Leyk (b32-ijo-46-02-0474) 2013; 126
Korolchuk, Menzies, Rubinsztein (b14-ijo-46-02-0474) 2010; 584
Hol, Fischer, Ovaa, Scheper (b33-ijo-46-02-0474) 2006; 6
Nawrocki, Carew, Maclean, Courage, Huang, Houghton, Cleveland, Giles, McConkey (b34-ijo-46-02-0474) 2008; 112
Richardson (key20180107183959_b1-ijo-46-02-0474) 2003; 348
Siegel (key20180107183959_b4-ijo-46-02-0474) 2012; 120
Hung (key20180107183959_b31-ijo-46-02-0474) 2013; 4
Kavanaugh (key20180107183959_b26-ijo-46-02-0474) 2010; 67
Zaarur (key20180107183959_b35-ijo-46-02-0474) 2014; 34
Mizushima (key20180107183959_b11-ijo-46-02-0474) 2008; 451
Olsen (key20180107183959_b25-ijo-46-02-0474) 2007; 25
Fusco (key20180107183959_b22-ijo-46-02-0474) 2012; 7
Verfaillie (key20180107183959_b10-ijo-46-02-0474) 2010; 2010
Kirkin (key20180107183959_b13-ijo-46-02-0474) 2009; 34
Komatsu (key20180107183959_b17-ijo-46-02-0474) 2012; 40
Hetz (key20180107183959_b8-ijo-46-02-0474) 2013; 12
Nawrocki (key20180107183959_b34-ijo-46-02-0474) 2008; 112
Komatsu (key20180107183959_b24-ijo-46-02-0474) 2013; 437
Kawaguchi (key20180107183959_b19-ijo-46-02-0474) 2003; 115
Haggarty (key20180107183959_b28-ijo-46-02-0474) 2003; 100
Martinon (key20180107183959_b7-ijo-46-02-0474) 2012; 51
Tabas (key20180107183959_b9-ijo-46-02-0474) 2011; 13
Maejima (key20180107183959_b39-ijo-46-02-0474) 2013; 32
Renna (key20180107183959_b38-ijo-46-02-0474) 2011; 121
Richardson (key20180107183959_b3-ijo-46-02-0474) 2014; 123
Ouyang (key20180107183959_b20-ijo-46-02-0474) 2012; 287
Hol (key20180107183959_b33-ijo-46-02-0474) 2006; 6
Korolchuk (key20180107183959_b14-ijo-46-02-0474) 2010; 584
Dimopoulos (key20180107183959_b5-ijo-46-02-0474) 2013; 14
Nakamura (key20180107183959_b36-ijo-46-02-0474) 2010; 37
Yan (key20180107183959_b23-ijo-46-02-0474) 2013; 8
Hubbert (key20180107183959_b27-ijo-46-02-0474) 2002; 417
Lee (key20180107183959_b21-ijo-46-02-0474) 2010; 29
San Miguel (key20180107183959_b2-ijo-46-02-0474) 2008; 359
Moriya (key20180107183959_b16-ijo-46-02-0474) 2013; 42
Mizushima (key20180107183959_b12-ijo-46-02-0474) 2011; 76
Simms-Waldrip (key20180107183959_b18-ijo-46-02-0474) 2008; 94
Richter-Landsberg (key20180107183959_b32-ijo-46-02-0474) 2013; 126
Garcia-Mata (key20180107183959_b29-ijo-46-02-0474) 1999; 146
Yamamoto (key20180107183959_b37-ijo-46-02-0474) 1998; 23
Johnston (key20180107183959_b30-ijo-46-02-0474) 1998; 143
Orlowski (key20180107183959_b6-ijo-46-02-0474) 2013; 40
Kawaguchi (key20180107183959_b15-ijo-46-02-0474) 2011; 38
22686473 - Acta Oncol. 2012 Sep;51(7):822-30
20145727 - Int J Cell Biol. 2010;2010:930509
21174067 - Int J Oncol. 2011 Mar;38(3):643-54
21804191 - J Clin Invest. 2011 Sep;121(9):3554-63
10491388 - J Cell Biol. 1999 Sep 20;146(6):1239-54
24135408 - Semin Oncol. 2013 Oct;40(5):634-51
23921551 - EMBO J. 2013 Aug 28;32(17):2336-47
23912309 - Acta Neuropathol. 2013 Dec;126(6):793-807
9864362 - J Cell Biol. 1998 Dec 28;143(7):1883-98
20075865 - EMBO J. 2010 Mar 3;29(5):969-80
22200786 - Int J Oncol. 2012 Apr;40(4):1029-39
22792322 - PLoS One. 2012;7(7):e40440
12677000 - Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4389-94
14675537 - Cell. 2003 Dec 12;115(6):727-38
24429336 - Blood. 2014 Mar 6;123(10):1461-9
19450525 - Mol Cell. 2009 May 15;34(3):259-69
21364565 - Nat Cell Biol. 2011 Mar;13(3):184-90
18472289 - Mol Genet Metab. 2008 Jul;94(3):283-6
24469403 - Mol Cell Biol. 2014 Apr;34(7):1336-48
12024216 - Nature. 2002 May 23;417(6887):455-8
23792097 - Biochem Biophys Res Commun. 2013 Jul 19;437(1):41-7
22833546 - Blood. 2012 Oct 4;120(14):2817-25
23989796 - Nat Rev Drug Discov. 2013 Sep;12(9):703-19
23817530 - Nat Commun. 2013;4:2111
18305538 - Nature. 2008 Feb 28;451(7182):1069-75
24086678 - PLoS One. 2013;8(9):e76016
22069321 - J Biol Chem. 2012 Jan 20;287(4):2317-27
18641367 - Blood. 2008 Oct 1;112(7):2917-26
18753647 - N Engl J Med. 2008 Aug 28;359(9):906-17
9639028 - Cell Struct Funct. 1998 Feb;23(1):33-42
20040365 - FEBS Lett. 2010 Apr 2;584(7):1393-8
24055414 - Lancet Oncol. 2013 Oct;14(11):1129-40
23546223 - Int J Oncol. 2013 May;42(5):1541-50
12826635 - N Engl J Med. 2003 Jun 26;348(26):2609-17
20811702 - Int J Oncol. 2010 Oct;37(4):815-20
21813637 - Cold Spring Harb Symp Quant Biol. 2011;76:397-402
20479100 - Am J Health Syst Pharm. 2010 May 15;67(10):793-7
17009921 - Expert Rev Neurother. 2006 Sep;6(9):1337-47
17577020 - J Clin Oncol. 2007 Jul 20;25(21):3109-15
References_xml – volume: 451
  start-page: 1069
  year: 2008
  end-page: 1075
  ident: b11-ijo-46-02-0474
  article-title: Autophagy fights disease through cellular self-digestion
  publication-title: Nature
– volume: 2010
  start-page: 930509
  year: 2010
  ident: b10-ijo-46-02-0474
  article-title: Linking ER stress to autophagy: potential implications for cancer therapy
  publication-title: Int J Cell Biol
– volume: 146
  start-page: 1239
  year: 1999
  end-page: 1254
  ident: b29-ijo-46-02-0474
  article-title: Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera
  publication-title: J Cell Biol
– volume: 32
  start-page: 2336
  year: 2013
  end-page: 2347
  ident: b39-ijo-46-02-0474
  article-title: Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury
  publication-title: EMBO J
– volume: 51
  start-page: 822
  year: 2012
  end-page: 830
  ident: b7-ijo-46-02-0474
  article-title: Targeting endoplasmic reticulum signaling pathways in cancer
  publication-title: Acta Oncol
– volume: 120
  start-page: 2817
  year: 2012
  end-page: 2825
  ident: b4-ijo-46-02-0474
  article-title: A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma
  publication-title: Blood
– volume: 40
  start-page: 1029
  year: 2012
  end-page: 1039
  ident: b17-ijo-46-02-0474
  article-title: Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells
  publication-title: Int J Oncol
– volume: 112
  start-page: 2917
  year: 2008
  end-page: 2926
  ident: b34-ijo-46-02-0474
  article-title: Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA
  publication-title: Blood
– volume: 100
  start-page: 4389
  year: 2003
  end-page: 4394
  ident: b28-ijo-46-02-0474
  article-title: Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
  publication-title: Proc Natl Acad Sci USA
– volume: 584
  start-page: 1393
  year: 2010
  end-page: 1398
  ident: b14-ijo-46-02-0474
  article-title: Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems
  publication-title: FEBS Lett
– volume: 23
  start-page: 33
  year: 1998
  end-page: 42
  ident: b37-ijo-46-02-0474
  article-title: Bafilomycin A prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells
  publication-title: Cell Struct Funct
– volume: 38
  start-page: 643
  year: 2011
  end-page: 654
  ident: b15-ijo-46-02-0474
  article-title: Combined treatment with bortezomib plus bafilomycin A enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: Crosstalk among proteasome, autophagy-lysosome and ER stress
  publication-title: Int J Oncol
– volume: 143
  start-page: 1883
  year: 1998
  end-page: 1898
  ident: b30-ijo-46-02-0474
  article-title: Aggresomes: a cellular response to misfolded proteins
  publication-title: J Cell Biol
– volume: 34
  start-page: 1336
  year: 2014
  end-page: 1348
  ident: b35-ijo-46-02-0474
  article-title: Proteasome failure promotes positioning of lysosomes around the aggresome via local block of microtubule-dependent transport
  publication-title: Mol Cell Biol
– volume: 6
  start-page: 1337
  year: 2006
  end-page: 1347
  ident: b33-ijo-46-02-0474
  article-title: Ubiquitin proteasome system as a pharmacological target in neurodegeneration
  publication-title: Expert Rev Neurother
– volume: 437
  start-page: 41
  year: 2013
  end-page: 47
  ident: b24-ijo-46-02-0474
  article-title: Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells
  publication-title: Biochem Biophys Res Commun
– volume: 42
  start-page: 1541
  year: 2013
  end-page: 1550
  ident: b16-ijo-46-02-0474
  article-title: Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells
  publication-title: Int J Oncol
– volume: 4
  start-page: 2111
  year: 2013
  ident: b31-ijo-46-02-0474
  article-title: Spatiotemporally controlled induction of autophagy-mediated lysosome turnover
  publication-title: Nat Commun
– volume: 417
  start-page: 455
  year: 2002
  end-page: 458
  ident: b27-ijo-46-02-0474
  article-title: HDAC6 is a microtubule-associated deacetylase
  publication-title: Nature
– volume: 121
  start-page: 3554
  year: 2011
  end-page: 3563
  ident: b38-ijo-46-02-0474
  article-title: Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
  publication-title: J Clin Invest
– volume: 14
  start-page: 1129
  year: 2013
  end-page: 1140
  ident: b5-ijo-46-02-0474
  article-title: Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
  publication-title: Lancet Oncol
– volume: 67
  start-page: 793
  year: 2010
  end-page: 797
  ident: b26-ijo-46-02-0474
  article-title: Vorinostat: a novel therapy for the treatment of cutaneous T-cell lymphoma
  publication-title: Am J Health Syst Pharm
– volume: 8
  start-page: e76016
  year: 2013
  ident: b23-ijo-46-02-0474
  article-title: SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity
  publication-title: PLoS One
– volume: 40
  start-page: 634
  year: 2013
  end-page: 651
  ident: b6-ijo-46-02-0474
  article-title: Novel agents for multiple myeloma to overcome resistance in phase III clinical trials
  publication-title: Semin Oncol
– volume: 76
  start-page: 397
  year: 2011
  end-page: 402
  ident: b12-ijo-46-02-0474
  article-title: Autophagy in protein and organelle turnover
  publication-title: Cold Spring Harb Symp Quant Biol
– volume: 348
  start-page: 2609
  year: 2003
  end-page: 2617
  ident: b1-ijo-46-02-0474
  article-title: A phase 2 study of bortezomib in relapsed, refractory myeloma
  publication-title: N Engl J Med
– volume: 34
  start-page: 259
  year: 2009
  end-page: 269
  ident: b13-ijo-46-02-0474
  article-title: A role for ubiquitin in selective autophagy
  publication-title: Mol Cell
– volume: 287
  start-page: 2317
  year: 2012
  end-page: 2327
  ident: b20-ijo-46-02-0474
  article-title: Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini
  publication-title: J Biol Chem
– volume: 12
  start-page: 703
  year: 2013
  end-page: 719
  ident: b8-ijo-46-02-0474
  article-title: Targeting the unfolded protein response in disease
  publication-title: Nat Rev Drug Discov
– volume: 7
  start-page: e40440
  year: 2012
  ident: b22-ijo-46-02-0474
  article-title: The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome
  publication-title: PLoS One
– volume: 94
  start-page: 283
  year: 2008
  end-page: 286
  ident: b18-ijo-46-02-0474
  article-title: The aggresome pathway as a target for therapy in hematologic malignancies
  publication-title: Mol Genet Metab
– volume: 359
  start-page: 906
  year: 2008
  end-page: 917
  ident: b2-ijo-46-02-0474
  article-title: Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
  publication-title: N Engl J Med
– volume: 115
  start-page: 727
  year: 2003
  end-page: 738
  ident: b19-ijo-46-02-0474
  article-title: The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
  publication-title: Cell
– volume: 37
  start-page: 815
  year: 2010
  end-page: 820
  ident: b36-ijo-46-02-0474
  article-title: Clarithromycin attenuates autophagy in myeloma cells
  publication-title: Int J Oncol
– volume: 29
  start-page: 969
  year: 2010
  end-page: 980
  ident: b21-ijo-46-02-0474
  article-title: HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy
  publication-title: EMBO J
– volume: 123
  start-page: 1461
  year: 2014
  end-page: 1469
  ident: b3-ijo-46-02-0474
  article-title: A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
  publication-title: Blood
– volume: 13
  start-page: 184
  year: 2011
  end-page: 190
  ident: b9-ijo-46-02-0474
  article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
  publication-title: Nat Cell Biol
– volume: 25
  start-page: 3109
  year: 2007
  end-page: 3115
  ident: b25-ijo-46-02-0474
  article-title: Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
  publication-title: J Clin Oncol
– volume: 126
  start-page: 793
  year: 2013
  end-page: 807
  ident: b32-ijo-46-02-0474
  article-title: Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration
  publication-title: Acta Neuropathol
– volume: 42
  start-page: 1541
  year: 2013
  ident: key20180107183959_b16-ijo-46-02-0474
  article-title: Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2013.1870
– volume: 348
  start-page: 2609
  year: 2003
  ident: key20180107183959_b1-ijo-46-02-0474
  article-title: A phase 2 study of bortezomib in relapsed, refractory myeloma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa030288
– volume: 146
  start-page: 1239
  year: 1999
  ident: key20180107183959_b29-ijo-46-02-0474
  article-title: Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera
  publication-title: J Cell Biol
  doi: 10.1083/jcb.146.6.1239
– volume: 29
  start-page: 969
  year: 2010
  ident: key20180107183959_b21-ijo-46-02-0474
  article-title: HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy
  publication-title: EMBO J
  doi: 10.1038/emboj.2009.405
– volume: 76
  start-page: 397
  year: 2011
  ident: key20180107183959_b12-ijo-46-02-0474
  article-title: Autophagy in protein and organelle turnover
  publication-title: Cold Spring Harb Symp Quant Biol
  doi: 10.1101/sqb.2011.76.011023
– volume: 38
  start-page: 643
  year: 2011
  ident: key20180107183959_b15-ijo-46-02-0474
  article-title: Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: Crosstalk among proteasome, autophagy-lysosome and ER stress
  publication-title: Int J Oncol
– volume: 40
  start-page: 1029
  year: 2012
  ident: key20180107183959_b17-ijo-46-02-0474
  article-title: Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2011.1317
– volume: 287
  start-page: 2317
  year: 2012
  ident: key20180107183959_b20-ijo-46-02-0474
  article-title: Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.273730
– volume: 37
  start-page: 815
  year: 2010
  ident: key20180107183959_b36-ijo-46-02-0474
  article-title: Clarithromycin attenuates autophagy in myeloma cells
  publication-title: Int J Oncol
– volume: 32
  start-page: 2336
  year: 2013
  ident: key20180107183959_b39-ijo-46-02-0474
  article-title: Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury
  publication-title: EMBO J
  doi: 10.1038/emboj.2013.171
– volume: 126
  start-page: 793
  year: 2013
  ident: key20180107183959_b32-ijo-46-02-0474
  article-title: Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-013-1158-x
– volume: 6
  start-page: 1337
  year: 2006
  ident: key20180107183959_b33-ijo-46-02-0474
  article-title: Ubiquitin proteasome system as a pharmacological target in neurodegeneration
  publication-title: Expert Rev Neurother
  doi: 10.1586/14737175.6.9.1337
– volume: 40
  start-page: 634
  year: 2013
  ident: key20180107183959_b6-ijo-46-02-0474
  article-title: Novel agents for multiple myeloma to overcome resistance in phase III clinical trials
  publication-title: Semin Oncol
  doi: 10.1053/j.seminoncol.2013.07.007
– volume: 451
  start-page: 1069
  year: 2008
  ident: key20180107183959_b11-ijo-46-02-0474
  article-title: Autophagy fights disease through cellular self-digestion
  publication-title: Nature
  doi: 10.1038/nature06639
– volume: 13
  start-page: 184
  year: 2011
  ident: key20180107183959_b9-ijo-46-02-0474
  article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb0311-184
– volume: 94
  start-page: 283
  year: 2008
  ident: key20180107183959_b18-ijo-46-02-0474
  article-title: The aggresome pathway as a target for therapy in hematologic malignancies
  publication-title: Mol Genet Metab
  doi: 10.1016/j.ymgme.2008.03.012
– volume: 12
  start-page: 703
  year: 2013
  ident: key20180107183959_b8-ijo-46-02-0474
  article-title: Targeting the unfolded protein response in disease
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3976
– volume: 100
  start-page: 4389
  year: 2003
  ident: key20180107183959_b28-ijo-46-02-0474
  article-title: Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0430973100
– volume: 51
  start-page: 822
  year: 2012
  ident: key20180107183959_b7-ijo-46-02-0474
  article-title: Targeting endoplasmic reticulum signaling pathways in cancer
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2012.689113
– volume: 120
  start-page: 2817
  year: 2012
  ident: key20180107183959_b4-ijo-46-02-0474
  article-title: A phase 2 study of single-agent carfilzomib (PX-171–003-A1) in patients with relapsed and refractory multiple myeloma
  publication-title: Blood
  doi: 10.1182/blood-2012-05-425934
– volume: 437
  start-page: 41
  year: 2013
  ident: key20180107183959_b24-ijo-46-02-0474
  article-title: Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.06.032
– volume: 359
  start-page: 906
  year: 2008
  ident: key20180107183959_b2-ijo-46-02-0474
  article-title: Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0801479
– volume: 34
  start-page: 259
  year: 2009
  ident: key20180107183959_b13-ijo-46-02-0474
  article-title: A role for ubiquitin in selective autophagy
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2009.04.026
– volume: 143
  start-page: 1883
  year: 1998
  ident: key20180107183959_b30-ijo-46-02-0474
  article-title: Aggresomes: a cellular response to misfolded proteins
  publication-title: J Cell Biol
  doi: 10.1083/jcb.143.7.1883
– volume: 121
  start-page: 3554
  year: 2011
  ident: key20180107183959_b38-ijo-46-02-0474
  article-title: Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
  publication-title: J Clin Invest
  doi: 10.1172/JCI46095
– volume: 2010
  start-page: 930509
  year: 2010
  ident: key20180107183959_b10-ijo-46-02-0474
  article-title: Linking ER stress to autophagy: potential implications for cancer therapy
  publication-title: Int J Cell Biol
  doi: 10.1155/2010/930509
– volume: 7
  start-page: e40440
  year: 2012
  ident: key20180107183959_b22-ijo-46-02-0474
  article-title: The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0040440
– volume: 4
  start-page: 2111
  year: 2013
  ident: key20180107183959_b31-ijo-46-02-0474
  article-title: Spatiotemporally controlled induction of autophagy-mediated lysosome turnover
  publication-title: Nat Commun
  doi: 10.1038/ncomms3111
– volume: 123
  start-page: 1461
  year: 2014
  ident: key20180107183959_b3-ijo-46-02-0474
  article-title: A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
  publication-title: Blood
  doi: 10.1182/blood-2013-07-517276
– volume: 67
  start-page: 793
  year: 2010
  ident: key20180107183959_b26-ijo-46-02-0474
  article-title: Vorinostat: a novel therapy for the treatment of cutaneous T-cell lymphoma
  publication-title: Am J Health Syst Pharm
  doi: 10.2146/ajhp090247
– volume: 417
  start-page: 455
  year: 2002
  ident: key20180107183959_b27-ijo-46-02-0474
  article-title: HDAC6 is a microtubule-associated deacetylase
  publication-title: Nature
  doi: 10.1038/417455a
– volume: 23
  start-page: 33
  year: 1998
  ident: key20180107183959_b37-ijo-46-02-0474
  article-title: Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells
  publication-title: Cell Struct Funct
  doi: 10.1247/csf.23.33
– volume: 14
  start-page: 1129
  year: 2013
  ident: key20180107183959_b5-ijo-46-02-0474
  article-title: Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(13)70398-X
– volume: 115
  start-page: 727
  year: 2003
  ident: key20180107183959_b19-ijo-46-02-0474
  article-title: The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
  publication-title: Cell
  doi: 10.1016/S0092-8674(03)00939-5
– volume: 584
  start-page: 1393
  year: 2010
  ident: key20180107183959_b14-ijo-46-02-0474
  article-title: Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2009.12.047
– volume: 8
  start-page: e76016
  year: 2013
  ident: key20180107183959_b23-ijo-46-02-0474
  article-title: SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0076016
– volume: 25
  start-page: 3109
  year: 2007
  ident: key20180107183959_b25-ijo-46-02-0474
  article-title: Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.10.2434
– volume: 112
  start-page: 2917
  year: 2008
  ident: key20180107183959_b34-ijo-46-02-0474
  article-title: Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA
  publication-title: Blood
  doi: 10.1182/blood-2007-12-130823
– volume: 34
  start-page: 1336
  year: 2014
  ident: key20180107183959_b35-ijo-46-02-0474
  article-title: Proteasome failure promotes positioning of lysosomes around the aggresome via local block of microtubule-dependent transport
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00103-14
– reference: 23792097 - Biochem Biophys Res Commun. 2013 Jul 19;437(1):41-7
– reference: 17577020 - J Clin Oncol. 2007 Jul 20;25(21):3109-15
– reference: 19450525 - Mol Cell. 2009 May 15;34(3):259-69
– reference: 20145727 - Int J Cell Biol. 2010;2010:930509
– reference: 20075865 - EMBO J. 2010 Mar 3;29(5):969-80
– reference: 23989796 - Nat Rev Drug Discov. 2013 Sep;12(9):703-19
– reference: 24135408 - Semin Oncol. 2013 Oct;40(5):634-51
– reference: 24086678 - PLoS One. 2013;8(9):e76016
– reference: 22200786 - Int J Oncol. 2012 Apr;40(4):1029-39
– reference: 22792322 - PLoS One. 2012;7(7):e40440
– reference: 9864362 - J Cell Biol. 1998 Dec 28;143(7):1883-98
– reference: 23921551 - EMBO J. 2013 Aug 28;32(17):2336-47
– reference: 14675537 - Cell. 2003 Dec 12;115(6):727-38
– reference: 21364565 - Nat Cell Biol. 2011 Mar;13(3):184-90
– reference: 20811702 - Int J Oncol. 2010 Oct;37(4):815-20
– reference: 23546223 - Int J Oncol. 2013 May;42(5):1541-50
– reference: 22686473 - Acta Oncol. 2012 Sep;51(7):822-30
– reference: 18305538 - Nature. 2008 Feb 28;451(7182):1069-75
– reference: 20040365 - FEBS Lett. 2010 Apr 2;584(7):1393-8
– reference: 17009921 - Expert Rev Neurother. 2006 Sep;6(9):1337-47
– reference: 22069321 - J Biol Chem. 2012 Jan 20;287(4):2317-27
– reference: 21174067 - Int J Oncol. 2011 Mar;38(3):643-54
– reference: 12826635 - N Engl J Med. 2003 Jun 26;348(26):2609-17
– reference: 18641367 - Blood. 2008 Oct 1;112(7):2917-26
– reference: 9639028 - Cell Struct Funct. 1998 Feb;23(1):33-42
– reference: 21804191 - J Clin Invest. 2011 Sep;121(9):3554-63
– reference: 18472289 - Mol Genet Metab. 2008 Jul;94(3):283-6
– reference: 22833546 - Blood. 2012 Oct 4;120(14):2817-25
– reference: 24429336 - Blood. 2014 Mar 6;123(10):1461-9
– reference: 21813637 - Cold Spring Harb Symp Quant Biol. 2011;76:397-402
– reference: 23817530 - Nat Commun. 2013;4:2111
– reference: 12677000 - Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4389-94
– reference: 10491388 - J Cell Biol. 1999 Sep 20;146(6):1239-54
– reference: 12024216 - Nature. 2002 May 23;417(6887):455-8
– reference: 24469403 - Mol Cell Biol. 2014 Apr;34(7):1336-48
– reference: 24055414 - Lancet Oncol. 2013 Oct;14(11):1129-40
– reference: 18753647 - N Engl J Med. 2008 Aug 28;359(9):906-17
– reference: 23912309 - Acta Neuropathol. 2013 Dec;126(6):793-807
– reference: 20479100 - Am J Health Syst Pharm. 2010 May 15;67(10):793-7
SSID ssj0025501
Score 2.3191867
Snippet The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
spandidos
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 474
SubjectTerms aggresome
Animals
Antibiotics
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Apoptosis - drug effects
Autophagy
Autophagy (Cytology)
Autophagy - drug effects
Boronic Acids - administration & dosage
Bortezomib
Cell death
Cell Line, Tumor
Clarithromycin - administration & dosage
Drug Synergism
Drug therapy
Endoplasmic reticulum
Endoplasmic Reticulum - drug effects
Endoplasmic Reticulum Stress - drug effects
ER stress
Health aspects
Histone Deacetylase 6
Histone Deacetylases - drug effects
Humans
Hydroxamic Acids - administration & dosage
Investigations
Kinases
Mice
Multiple myeloma
Multiple Myeloma - drug therapy
Multiple Myeloma - genetics
Multiple Myeloma - pathology
Physiological aspects
proteasome
Proteasome Endopeptidase Complex - drug effects
Proteins
Pyrazines - administration & dosage
Title Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress-mediated cell death in multiple myeloma cells
URI https://www.ncbi.nlm.nih.gov/pubmed/25422130
https://www.proquest.com/docview/1932824904
https://pubmed.ncbi.nlm.nih.gov/PMC4277245
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJgEviG8C2_ADgpeaJY4Tp09omzpNSK2maZP6Fjm2M4rWpJDuYX8J_y53Tpotk4bUl9bX2ul9_c6-OwN8DnVGbjvkUeli2q3SvFBK8USnodVZmpUlFSdPZ-nJhfwxT-bdhlvTpVVubKI31LY2tEe-T0Ajw1ghlN9XvzndGkWnq90VGo9hm1qXkVSr-W3AhejbB1wIYzh53rbHJrposb_4RZV_kfwmlIoHPum-Zb7jmu6nTT5Fpa_swtbNHZ90_AKed2CSHbTcfwmPXPUKnky74_LX8Pfc53mjd2KI81jfGsKyqs3-blhdMn1JMXe9dKyvZBwx379B06cjhrMzfU0dCPTlDVvhQIV2ATEqm5yxttiE-woU-mU6CWCWgCXOxzb5imx5467qpfbDzRu4OJ6cH53w7iYGbtIoWvNMGGEcMk4LUcZGhONYurEyKotM4ZLQqQJfGJDKJDS2KJJC6dCmRo-dw_gvjd_CVlVX7j2wDG2KSaxwcWQlWtvCjENnU4tICcGCVgGMNrzITdemnG7LuMoxXCHW5ci6nFiXE-sC-NKTr9r-HA8RfiLG5m15aa_X-QEFmBmGlVkAXz0FaTbOaHRXoIDrph5ZA8qdASVqpBkOb4Qn7yxCk9_KbwDvWjnqF4xBuhAIJgJQAwnrCagH-HCkWvz0vcAlPpuQSQCsl8X-W_j8XLYp5lLJD_9f1Ud4hv9V0iak78DW-s-120W8tS72vFLtwfbhZHZ6hu9mp9N_e94uWg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlEuiDeGQvfA4xK39nrtdQ4IVdAqpU0PKJVyM-vddUnV2ClOhfJL-Bf8Rmb8al0JbpVyyk7sdWZ25vu8M7MAbz0VU9j2XD-zAb2tUm4qpXRDFXlGxVGcZVScPD6ORifi6zScrsGfthaG0ipbn1g5alNoeke-Q0AjRq7giU-LC5dOjaLd1fYIjdosDu3qF1K28uPBF9TvO8739yafR25zqoCrI99fujHXXFuchOI8CzRHSi_sUGoZ-zq1oWdlih8kVyL0tEnTMJXKM5FWQ2uRy0QBXvcO3MXA6xHZk9MrgodovyJ4CJtcivR1T0-EBHxndkaVhr7Y5lIGvRh4MxJcC4U30zQ30MnkZmaK8loM3H8IDxrwynZra3sEazZ_DPfGzfb8E_g9qfLKMRoyxJWsa0VhWF5nm5esyJg6JY5fzC3rKicHrOoXoejbAcO7M3VJHQ_U6YotcCBHP4SYmO19Y3Vxi1tVvNCVaeeBGQKyeD_W5key-cqeF3NVDZdP4eRWdPQM1vMity-AxejDdGi4DXwj0LuneuhZExlEZghOlHRg0Ooi0U1bdDqd4zxBekSqS1B1CakuIdU58L4TX9T9QP4luEWKTepy1s6PJLtEaGOksbEDHyoJ8iR4R62aggicN_Xk6klu9iTRA-j-cGs8SeOByuRqvTjwvLajbsI8FJwjeHFA9iysE6Ce4_2RfPaj6j0u8Nm4CB1gnS12v8Lnd0Wd0i6kePn_WW3BxmgyPkqODo4PX8F9_N_COhl-E9aXPy_ta8R6y_RNtcAYfL_tFf0XSglphw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVCpcEG8Mhe6BxyUm9nrtdQ4IFZqopTSqqlbqzV3vrktQYweSCuWX8F_4dcz4RV0JbpVyyk7sdWZ25vu8M7MArzwVU9j2XD-zAb2tUm4qpXRDFXlGxVGcZVScfDCJdk_E59PwdA1-N7UwlFbZ-MTSUZtC0zvyAQGNGLmCJwZZnRZxuDP-MP_u0glStNPaHKdRmci-Xf1E-rZ4v7eDun7N-Xh0_GnXrU8YcHXk-0s35pprixNSnGeB5kjvhR1KLWNfpzb0rEzxg0RLhJ42aRqmUnkm0mpoLfKaKMDr3oJ1SayoB-sfR5PDo5buIfYv6R6CKJfiftXhEwECH0y_Ud2hL95xKYNORLweF64ExutJm7fR5eRmaorFlYg4vgd3ayjLtivbuw9rNn8AGwf1Zv1D-HVcZpljbGSIMlnbmMKwvMo9X7AiY-qcGH8xs6yto-yzsnuEom_7DO_O1CX1P1DnKzbHgRy9EiJkNjpiVamLW9a_0JVpH4IZgrV4P9ZkS7LZyl4UM1UOLx7ByY1o6TH08iK3T4HF6NF0aLgNfCPQ16d66FkTGcRpCFWUdKDf6CLRdZN0OqvjIkGyRKpLUHUJqS4h1TnwphWfV91B_iW4RYpNquLW1qsk20RvYyS1sQNvSwnyK3hHreryCJw3dejqSG52JNEf6O5wYzxJ7Y8Wyd_V48CTyo7aCfNQcI5QxgHZsbBWgDqQd0fy6deyE7nAZ-MidIC1ttj-Cp_fFVWCu5Di2f9ntQUbuJqTL3uT_edwB_-2sMqM34Te8selfYHAb5m-rFcYg7ObXtR_ACS6byI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+the+integrated+networks+of+aggresome+formation%2C+proteasome%2C+and+autophagy+potentiates+ER+stress-mediated+cell+death+in+multiple+myeloma+cells&rft.jtitle=International+journal+of+oncology&rft.au=MORIYA%2C+SHOTA&rft.au=KOMATSU%2C+SEIICHIRO&rft.au=YAMASAKI%2C+KAHO&rft.au=KAWAI%2C+YUSUKE&rft.date=2015-02-01&rft.pub=D.A.+Spandidos&rft.issn=1019-6439&rft.eissn=1791-2423&rft.volume=46&rft.issue=2&rft.spage=474&rft.epage=486&rft_id=info:doi/10.3892%2Fijo.2014.2773&rft_id=info%3Apmid%2F25422130&rft.externalDocID=PMC4277245
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1019-6439&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1019-6439&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1019-6439&client=summon